Tiny heart monitor could unlock secrets of deadly rhythms in amyloidosis
NCT ID NCT04856267
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed study looked at 110 people with cardiac amyloidosis, a condition where protein deposits build up in the heart. Researchers implanted a small device under the skin to continuously monitor heart rhythms for up to several years. The goal was to learn more about when and why dangerous abnormal heartbeats occur, which could help doctors decide when to use treatments like pacemakers. Participants may not have directly benefited, but the data could improve care for future patients.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
implantable loop recorder (LINQ device)
What this could lead to
If successful, this study could help doctors better predict and prevent dangerous heart rhythms in people with cardiac amyloidosis, potentially saving lives.
What could go wrong
This is an observational study, not a treatment trial. It may not directly benefit participants, and the findings might not change current care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIAC AMYLOIDOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Royal Free London NHS Foundation Trust
London, NW3 2QG, United Kingdom